[Table/Fig-3]:
Showed intra-group comparison of PFT parameters.
| PARAMETERS | GROUP -1 (ACEBROPHYLLIN E) | GROUP -2 (SR TH EOPHYLLIN E) | ||||||||||||||||
| FEV1 | Visit-1 | Visit-2 | p-value | Visit-2 | Visit-3 | p-value | Visit-1 | Visit-3 | p-value | Visit-1 | Visit-2 | p-value | Visit-2 | Visit-3 | p-value | Visit-1 | Visit-3 | p-value |
| 66.28±7.64 | 66.75±7.71 | 0.0001* | 66.75±7.71 | 67.52±7.93 | 0.003* | 66.28±7.64 | 67.52±7.93 | 0.0001* | 65.71±7.73 | 65.76±7.86 | 0.304 | 65.76±7.86 | 66.07±8.04 | 0.0005* | 65.71±7.73 | 66.07±8.04 | 0.001* | |
| FEV1/FVC | Visit-1 | Visit-2 | p-value | Visit-2 | Visit-3 | p-value | Visit-1 | Visit-3 | p-value | Visit-1 | Visit-2 | p-value | Visit-2 | Visit-3 | p-value | Visit-1 | Visit-3 | p-value |
| 57.91±9.66 | 58.21±9.68 | 0.0001* | 58.21±9.68 | 58.54±9.82 | 0.0005* | 57.91±9.66 | 58.54±9.82 | 0.0001* | 57.59±9.46 | 57.53±9.67 | 0.44 | 57.53±9.67 | 57.75±9.75 | 0.0008* | 57.59±9.46 | 57.75±9.75 | 0.11 | |
| FEF25-75% | Visit-1 | Visit-2 | p-value | Visit-2 | Visit-3 | p-value | Visit-1 | Visit-3 | p-value | Visit-1 | Visit-2 | p-value | Visit-2 | Visit-3 | p-value | Visit-1 | Visit-3 | p-value |
| 40.14±5.81 | 40.46±5.75 | 0.008* | 40.46±5.75 | 40.77±5.83 | 0.0002* | 40.14±5.81 | 40.77±5.83 | 0.0001* | 39.83±5.85 | 39.89±5.83 | 0.36 | 39.89±5.83 | 40.08±6.01 | 0.05* | 39.83±5.85 | 40.08±6.01 | 0.02* | |
| PEFR | Visit-1 | Visit-2 | p-value | Visit-2 | Visit-3 | p-value | Visit-1 | Visit-3 | p-value | Visit-1 | Visit-2 | p-value | Visit-2 | Visit-3 | p-value | Visit-1 | Visit-3 | p-value |
| 46.13±6.43 | 46.54±6.14 | 0.11 | 46.54±6.14 | 46.7±6.29 | 0.48 | 46.13±6.43 | 46.7±6.29 | 0.01* | 46.01±6.51 | 45.99±6.63 | 0.76 | 45.99±6.63 | 46.44±6.53 | 0.33 | 46.01±6.51 | 46.44±6.53 | 0.36 | |
p-value <0.05* was considered to be significantInhaled